US FDA gives clearance to AffaMed’s bispecific biologic to treat retinal vascular diseases
AffaMed will soon initiate a phase-I study in the US to investigate the safety, tolerability, pharmacokinetics and efficacy of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.